YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Body Distribution of $^{125}I-rhEGF$ Across Normal and Damaged Rat Skins

정상 및 손상된 흰쥐 피부에 국소 적용된 $^{125}I-rhEGF$의 체내 이행

  • Published : 1997.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Distribution of radioactivity in the skin tissues, subcutaneous tissues, blood and body organs was examined following topical application of $^{125}I-rhEGF$(0.4 ${\mu}Ci$), in the form of a Pluronic F-127 gel, on the normal and damaged (burned and stripped) skins of SD male rats. The radioactivity in the skin tissues and subcutaneous tissues was 3-5 times higher for the damaged skins than for the normal skin. But pretreatment of the skin with rhEGF (1${\mu}g$)) twice at 24 hr dose intervals affected the distribution of the radioactivity yielding the order of burned skin> stripped skin=normal skin. The decrease for the stripped skin by the pretreatment might be related either to the pathophysiological change of the skin or to the down regulation of the EGF receptor. Liver showed the highest radioactivity in amount following single and multiple administration of the drug to the normal and damaged skins. But,in concentration, the kidney and stomach showed higher value than the liver which is consistent with that kidney is a major eliminating organ of EGF and that EGF exerts its pharmacological effect specifically for the stomach.

Keywords

References

  1. The Molecular and Cellular Biology of Wound Repair The role of growth factors in tissue repair Ⅱ Banks, A. R.;Clark, R. A. F.(Ed.);Henson, P. M.(Ed.)
  2. Endocr. Rev. v.11 Metabolism and effects of epidermal growth factor and related growth factors in mammals Fisher, D. A.;Lakshmanan, J.
  3. Biol. Pharm. Bull v.16 Cytoprotective effects of epidermal growth factor (EGF) ointment containing nafamostat, a protease inhibitor, on tissue damage at burn sites in rats Kiyohara, Y.;Nishiguchi, K.;Komada, F.;Iwakawa, S.;Hirai, M.;Okumura, K.
  4. Yakhak Hoeji v.41 Pharmacokinetics of recombinant human epidermal growth factor (DWP401) in rats Chung, J. Y.;Koh, Y. W.;Nam, K. H.;Yoo, E. S.;Park, S. K.;Yu, Y. H.;Park, M. H.;Shim, C. K.
  5. Int. J. Pharm. v.46 Intravenous and subcutaneous pharmacokinetics and rectal bioavailability of human epidermal growth factor in the presence of absorption promoter in the rats Murakami, T.;Kawakita, H.;Kishimoto, M.;Higashi, Y.;Amagase, H.;Hayashi, T.;Nojima, N.;Fuwa, T.;Yata, N.
  6. Regul. Pept. v.23 Distribution of intravenous administered EGF in the rat Jφrgensen, P. E.;Poulsen, S. S.;Nex, S. E.
  7. Ph. D. Thesis, University of Rhode Island Topical formulation of epidermal growth factor for wound healing Dibiase, M. D. G.
  8. Pharm. Res. v.7 Improvement in wound healing by EGF ointment Ⅰ. Effect of nafamostat, gabexate or gelatin on stabilization and efficacy of EGF Okumura, K.;Kiyohara, Y.;Komada, F.;Iwakawa, S.;Hirai, M.;Fuwa, T.
  9. J. Pharmacobio-Dyn. v.14 Improvement in wound healing by EGF ointment Ⅱ. Effect of protease inhibitor, nafamostat on stabilization and efficacy of EGF in burn Kiyohara, Y.;Komada, F.Iwakawa, S.;Hirai, M.;Fuwa, T.;Okumura, K.
  10. Biol. Pharm. Bull. v.16 Systemic effects of EGF ointment containing protease inhibitor or gelatin in rats with burns or open wounds Kiyohara, Y.;Komada, F.;Iwakawa, S.;Fuwa, T.;Okumura, K.
  11. Protein pharmacokinetics and metabolism Goals and analytical methodologies for protein disposition studies Ferraiolo, B. L.;Mohler, M. A.
  12. Biochem. Pharmacol. v.38 Kinetic analysis of the elimination process of hEGF in rats Kim, D. C.;Sugiyama, Y.;Fuwa, T.;Sakamoto, S.;Iga, T.;Hanano, M.
  13. Am. J. Physiol. v.261 Kinetic analysis of clearance of epidermal growth factor in isolated perfused rat kidney Kim, D. C.;Hanano, M.;Sawada, Y.;Iga, T.;Sugiyama, Y.